Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
Long-Term Investments
Middle East Pharmaceutical Industries Company SJSC
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
Long-Term Investments
ď·Ľ1.3m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
|
Long-Term Investments
ď·Ľ61.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-33%
|
|
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
Long-Term Investments
ď·Ľ57.5m
|
CAGR 3-Years
144%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
What is Middle East Pharmaceutical Industries Company SJSC's Long-Term Investments?
Long-Term Investments
1.3m
SAR
Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Long-Term Investments amounts to 1.3m SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-61%
Over the last year, the Long-Term Investments growth was -63%. The average annual Long-Term Investments growth rates for Middle East Pharmaceutical Industries Company SJSC have been -61% over the past three years .
You don't have any saved screeners yet